Back to Results
First PageMeta Content
Health / Lactams / Dobutamine / MedWatch / Lorazepam / Adverse effect / Medicine / Hospira / Antiemetics


HOSPIRA ANNOUNCES VOLUNTARY NATIONWIDE RECALL OF ONE LOT OF DOBUTAMINE INJECTION, USP, 250 mg, 20 mL, Single-dose Fliptop Vial, DUE TO VISIBLE PARTICULATES
Add to Reading List

Document Date: 2014-11-25 12:02:47


Open Document

File Size: 156,84 KB

Share Result on Facebook

City

LAKE FOREST / /

Company

VOLUNTARY NATIONWIDE / Hospira Inc. / Stericycle / /

Event

Product Release / Product Issues / Product Recall / /

/

IndustryTerm

healthcare costs / report Online / infusion technologies / /

MedicalCondition

granuloma formation / bacteremia / shortness of breath / sterility / shock / local inflammation / nausea / phlebitis / fever / Septicemia / vomiting / pain / septic shock / endocarditis / tachycardia / sepsis / /

Organization

U.S. Food and Drug Administration / FDA / /

Person

LOT OF DOBUTAMINE / /

/

Product

DOBUTAMINE INJECTION / This / VOLUNTARY NATIONWIDE RECALL / HOSPIRA ANNOUNCES VOLUNTARY NATIONWIDE RECALL OF ONE LOT OF DOBUTAMINE INJECTION / vial / solution / /

ProgrammingLanguage

ML / /

ProvinceOrState

Illinois / /

Technology

infusion technologies / /

URL

www.fda.gov/medwatch/report.htm / www.hospira.com / www.fda.gov/MedWatch/getforms.htm / /

SocialTag